A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma.
Grignol VP, Olencki T, Relekar K, Taylor C, Kibler A, Kefauver C, Wei L, Walker MJ, Chen HX, Kendra K, Carson WE 3rd.
Grignol VP, et al. Among authors: carson we 3rd.
J Immunother. 2011 Jul-Aug;34(6):509-15. doi: 10.1097/CJI.0b013e31821dcefd.
J Immunother. 2011.
PMID: 21654521
Free PMC article.
Clinical Trial.